SS Innovations International (SSII) EBIT Growth (1y) (2017 - 2026)
SS Innovations International (SSII) EBIT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 90.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 74.18% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 38.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.55% |
| Dec 31, 2025 | 60.03% |
| Sep 30, 2025 | 42.73% |
| Jun 30, 2025 | 102.37% |
| Mar 31, 2025 | 39.77% |
| Dec 31, 2024 | 84.88% |
| Sep 30, 2024 | -73.03% |
| Jun 30, 2024 | 21.02% |
| Mar 31, 2024 | -818.37% |
| Dec 31, 2023 | -1,286.52% |
| Sep 30, 2023 | -335.38% |
| Jun 30, 2023 | -615.97% |
| Mar 31, 2023 | -1,231.86% |
| Dec 31, 2022 | -147.87% |
| Sep 30, 2022 | -1.73% |
| Jun 30, 2022 | -75.87% |
| Mar 31, 2022 | 73.21% |
| Dec 31, 2021 | -59.56% |
| Sep 30, 2021 | -11.45% |
| Jun 30, 2021 | -87.41% |